FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767797435> ?p ?o ?g. }

• W2767797435 endingPage "14" @default.
• W2767797435 startingPage "1" @default.
• W2767797435 abstract "Psoriasis is a chronic autoimmune disease which affects millions of people worldwide. Not only can psoriasis itself be debilitating and significantly reduce an individual's quality of life, but it is also a risk factor for other systemic disorders, such as metabolic syndrome, cardiovascular disease, and malignancy. Tremendous strides were made in the treatment of psoriasis during the mid-to-late-20th century, including the emergence of topical corticosteroids and vitamin D analogs, methotrexate, systemic retinoids, and phototherapy. However, it was not until 2004 with the advent of systemic biologic agents, which precisely target components of the immune system involved in the pathophysiological process of psoriasis, that the primary treatment benchmark increased from 50% improvement in the Psoriasis Area and Severity Index (PASI 50) to PASI 75, PASI 90, and even PASI 100, or complete resolution of cutaneous disease. Today, many patients receiving biologic therapy routinely experience greater than 75% or 90% reduction in cutaneous disease burden and a significant improvement in overall quality of life. These biologic agents are generally well-tolerated and safe but, like any medication, have associated adverse effects, some of which are predictable based on the effects of immune modulation, animal model studies, and human populations with known cytokine deficiencies. Going forward, it will be important to carefully monitor the safety profiles of these agents in both clinical trials and post-marketing surveillance registries to ensure long-term safety. It is reassuring that large safety registries are consistent in demonstrating an improved safety profile with newer and emerging biologic therapies." @default.
• W2767797435 created "2017-11-17" @default.
• W2767797435 creator A5025260885 @default.
• W2767797435 creator A5038083335 @default.
• W2767797435 creator A5059337854 @default.
• W2767797435 date "2017-11-07" @default.
• W2767797435 modified "2023-09-25" @default.
• W2767797435 title "Adverse Reactions to Biologics in Psoriasis" @default.
• W2767797435 cites W1521666696 @default.
• W2767797435 cites W1541913191 @default.
• W2767797435 cites W1661616496 @default.
• W2767797435 cites W1809686743 @default.
• W2767797435 cites W1858749428 @default.
• W2767797435 cites W1870006248 @default.
• W2767797435 cites W1943930704 @default.
• W2767797435 cites W1959946112 @default.
• W2767797435 cites W1969629625 @default.
• W2767797435 cites W1969991375 @default.
• W2767797435 cites W1971437428 @default.
• W2767797435 cites W1973354423 @default.
• W2767797435 cites W1975463338 @default.
• W2767797435 cites W1981383482 @default.
• W2767797435 cites W1986494794 @default.
• W2767797435 cites W1988914585 @default.
• W2767797435 cites W1994119541 @default.
• W2767797435 cites W1995768724 @default.
• W2767797435 cites W1995839269 @default.
• W2767797435 cites W1997066664 @default.
• W2767797435 cites W1997192647 @default.
• W2767797435 cites W2003560472 @default.
• W2767797435 cites W2007990430 @default.
• W2767797435 cites W2008716526 @default.
• W2767797435 cites W2014075805 @default.
• W2767797435 cites W2022665587 @default.
• W2767797435 cites W2023380729 @default.
• W2767797435 cites W2023928995 @default.
• W2767797435 cites W2024163966 @default.
• W2767797435 cites W2024357543 @default.
• W2767797435 cites W2033458234 @default.
• W2767797435 cites W2044517619 @default.
• W2767797435 cites W2047734525 @default.
• W2767797435 cites W2050104340 @default.
• W2767797435 cites W2052898192 @default.
• W2767797435 cites W2054089499 @default.
• W2767797435 cites W2054314232 @default.
• W2767797435 cites W2056468769 @default.
• W2767797435 cites W2058547807 @default.
• W2767797435 cites W2058927737 @default.
• W2767797435 cites W2060546762 @default.
• W2767797435 cites W2061084002 @default.
• W2767797435 cites W2063627867 @default.
• W2767797435 cites W2064809740 @default.
• W2767797435 cites W2065523538 @default.
• W2767797435 cites W2075382650 @default.
• W2767797435 cites W207589287 @default.
• W2767797435 cites W2076116648 @default.
• W2767797435 cites W2080165152 @default.
• W2767797435 cites W2080390872 @default.
• W2767797435 cites W2085033218 @default.
• W2767797435 cites W2087777607 @default.
• W2767797435 cites W2091442391 @default.
• W2767797435 cites W2093455167 @default.
• W2767797435 cites W2102980544 @default.
• W2767797435 cites W2103750969 @default.
• W2767797435 cites W2105833786 @default.
• W2767797435 cites W2108827080 @default.
• W2767797435 cites W2109043847 @default.
• W2767797435 cites W2109163445 @default.
• W2767797435 cites W2116956799 @default.
• W2767797435 cites W2122865429 @default.
• W2767797435 cites W2129777700 @default.
• W2767797435 cites W2132784721 @default.
• W2767797435 cites W2132978141 @default.
• W2767797435 cites W2136553919 @default.
• W2767797435 cites W2140101720 @default.
• W2767797435 cites W2143003624 @default.
• W2767797435 cites W2143565464 @default.
• W2767797435 cites W2149566497 @default.
• W2767797435 cites W2150933492 @default.
• W2767797435 cites W2152973730 @default.
• W2767797435 cites W2163232748 @default.
• W2767797435 cites W2167404036 @default.
• W2767797435 cites W2168911501 @default.
• W2767797435 cites W2171889601 @default.
• W2767797435 cites W2172257129 @default.
• W2767797435 cites W2322390243 @default.
• W2767797435 cites W2324298557 @default.
• W2767797435 cites W2329428908 @default.
• W2767797435 cites W2345636825 @default.
• W2767797435 cites W2359919307 @default.
• W2767797435 cites W2401279855 @default.
• W2767797435 cites W2411193013 @default.
• W2767797435 cites W2412116831 @default.
• W2767797435 cites W2418506270 @default.
• W2767797435 cites W2422451409 @default.
• W2767797435 cites W2512873140 @default.
• W2767797435 cites W2516755733 @default.
• W2767797435 cites W2521243079 @default.

• next